Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- BUSINESS NEWS IN BRIEF
January 26, 2004
- WEBSITE NEWS
January 26, 2004
- Target Approval Times for Ethical Drugs to Be Announced by April
January 26, 2004
- Korosho Studying Drug Review Update System
January 26, 2004
- Medical Expenses for 20 EBM GL-covered Diseases Account for 30% of Total, \7.3 Trillion
January 26, 2004
- Off-label Use of 15 Drugs to Be Reimbursed
January 26, 2004
- Korosho Calls For Withholding of Applications in March
January 26, 2004
- REGULATORY NEWS IN BRIEF
January 26, 2004
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
January 26, 2004
- BULLETIN
January 26, 2004
- NEW PRODUCTS
January 26, 2004
- 5 Top Products Exceed Sales of \30 Billion Each: PJ Survey
January 26, 2004
- Kyoto Univ. Invites Regional Med. Facilities to Clinical Study on ASO
January 26, 2004
- Tamiflu Should be Limited to Patients One Year of Age or Older
January 26, 2004
- OTC NEWS IN BRIEF
January 26, 2004
- Sumitomo, AstraZeneca Ink Joint Research Agreement for Respiratory Drugs
January 26, 2004
- MEDICAL DEVICE NEWS IN BRIEF
January 26, 2004
- FY 2004 Business Plan Approved: JPMA General Assembly
January 19, 2004
- BUSINESS NEWS IN BRIEF
January 19, 2004
- CORPORATE ROUNDUP NEWS IN BRIEF
January 19, 2004
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…